Blood Glucose Control

Trial assesses if link exists between severe hypoglycemia and adverse cardiovascular outcomes in veterans.

Personalized messages based on motivational interviewing principles compared to usual care to determine if any significant difference in self-management of type 2 diabetes.

Guest Post by David Kliff, Editor, Diabetic Investor
Although we haven’t gotten there just yet, it’s no longer a question of if type 2’s start using CGM, but when they do and how they use it. CGM is not like an insulin pump when it comes to having a finite market size. CGM is a valuable tool regardless of whether the patient uses insulin.

Time in glycemic range inversely correlated to risk of developing vascular complications in patients with diabetes

Study assesses effect of variable glycemic levels on risk of vascular complication in patients without diabetes.

Study attempts to determine association between elevated triglyceride levels and achieving glycemic goals for those with insulin-treated diabetes.

Will perceived quality of life be affected by increasing antidiabetes medication burden on the patient?

Study assesses effect of new add-on therapy.

Infection risk is high among people with diabetes, but can better glycemic management improve lower infection risk?

The best medication therapy for an individual with type 2 diabetes can depend on many factors, including ethnicity and multiple drug options.